Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Biophysical constraints on mRNA decay rates shape macroevolutionary divergence in steady-state abundances
Evolutionary changes to gene expression are understood to be a major driver of phenotypic divergence between species. Researchers have investigated the drivers of this...
Benchmarking with synthetic communities provides a baseline for virus-host inferences from Hi-C proximity linking
by Rokaiya Nurani Shatadru, Natalie E. Solonenko, Christine L. Sun, Matthew B. Sullivan Microbiomes influence diverse ecosystems, and viruses increasingly appear to imp...
Roche inks deal for rights to Freenome cancer tests outside US - MedTech Dive
Roche inks deal for rights to Freenome cancer tests outside US MedTech Dive
Roche pill notches win in early breast cancer - BioPharma Dive
Roche pill notches win in early breast cancer BioPharma Dive
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
Roche’s MS tablet scores in late-stage studies BioPharma Dive
Illumina says China is lifting export ban - MedTech Dive
Illumina says China is lifting export ban MedTech Dive
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
Roche taps an AI specialist to craft new brain drugs BioPharma Dive
Agilent selects Adam Elinoff as CFO - MedTech Dive
Agilent selects Adam Elinoff as CFO The appointment fills a position made available when Bob McMahon resigned as CFO on July 31. Published Oct. 31, 2025 By Nick Paul Ta...
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B - MedTech Dive
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B MedTech Dive
Roche Earnings: We’re Slightly Lowering Our 2025 Sales Forecast but Encouraged by Diverse Pipeline - Morningstar Canada
Roche Earnings: We’re Slightly Lowering Our 2025 Sales Forecast but Encouraged by Diverse Pipeline Morningstar Canada
Roche dives into MASH with $2.4B deal for 89bio - BioPharma Dive
Roche dives into MASH with $2.4B deal for 89bio BioPharma Dive
DOJ reaches $9.8M settlement with Illumina over cyber whistleblower claims - MedTech Dive
DOJ reaches $9.8M settlement with Illumina over cyber whistleblower claims MedTech Dive
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims - Cybersecurity Dive
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims Cybersecurity Dive
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
Illumina to buy SomaLogic in deal worth up to $425M BioPharma Dive
SEC ends probe of Illumina’s Grail acquisition - MedTech Dive
SEC ends probe of Illumina’s Grail acquisition MedTech Dive
Illumina’s DNA sequencers hit with China import ban - MedTech Dive
Illumina’s DNA sequencers hit with China import ban MedTech Dive
Illumina placed on China’s unreliable entity list - MedTech Dive
Illumina placed on China’s unreliable entity list MedTech Dive
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page